Related references
Note: Only part of the references are listed.ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome
Fu Zhong et al.
LIPIDS IN HEALTH AND DISEASE (2022)
VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses
Yilan Shen et al.
ACTA PHARMACEUTICA SINICA B (2021)
A haplotype of the ANGPTL3 gene is associated with CVD risk, diabetes mellitus, hypertension, obesity, metabolic syndrome, and dyslipidemia
Malihe Aghasizadeh et al.
GENE (2021)
Update on diagnosis, pathophysiology, and management of diabetic kidney disease
Mai Sugahara et al.
NEPHROLOGY (2021)
An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
Nicholas M. Selby et al.
DIABETES OBESITY & METABOLISM (2020)
The association between genetic variants of angiopoietin-like 3 and risk of diabetes mellitus is modified by dietary factors in Koreans
Clara Yongjoo Park et al.
SCIENTIFIC REPORTS (2019)
Angiopoietin-like-3 knockout protects against glomerulosclerosis in murine adriamycin-induced nephropathy by attenuating podocyte loss
Rufeng Dai et al.
BMC NEPHROLOGY (2019)
Targeted Interleukin-22 Gene Delivery in the Liver by Polymetformin and Penetratin-Based Hybrid Nanoparticles to Treat Nonalcoholic Fatty Liver Disease
Wenjing Zai et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy
Wai Han Yiu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism
Guang Liang et al.
KIDNEY INTERNATIONAL (2018)
Hydrogen Sulfide Attenuates LPS-Induced Acute Kidney Injury by Inhibiting Inflammation and Oxidative Stress
Yuhong Chen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics
Wei Chen et al.
BIOMATERIALS (2018)
The role of the complement system in diabetic nephropathy
Allan Flyvbjerg
NATURE REVIEWS NEPHROLOGY (2017)
Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
Shaofei Wang et al.
CELL DEATH & DISEASE (2017)
LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy
Hong Yi et al.
CELL DEATH & DISEASE (2017)
Tethering Interleukin-22 to Apolipoprotein A-I Ameliorates Mice from Acetaminophen-induced Liver Injury
Wei Chen et al.
THERANOSTICS (2017)
Innate immunity in diabetes and diabetic nephropathy
Jun Wada et al.
NATURE REVIEWS NEPHROLOGY (2016)
Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-κB and NLRP3 inflammasome
Yara A. Samra et al.
LIFE SCIENCES (2016)
miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy
Yan Sun et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Albuminuria in type 2 diabetes mellitus: from remission to progression
Yassamine Bentata et al.
RENAL FAILURE (2016)
Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy
Yang Zhang et al.
ACTA DIABETOLOGICA (2015)
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Mark E. Molitch et al.
KIDNEY INTERNATIONAL (2015)
A novel role of angiopoietin-like-3 associated with podocyte injury
Junchao Liu et al.
PEDIATRIC RESEARCH (2015)
A vital role for Angptl3 in the PAN-induced podocyte loss by affecting detachment and apoptosis in vitro
Rufeng Dai et al.
BMC NEPHROLOGY (2015)
Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
Ivonne Loeffler et al.
CELLS (2015)
A Potential Role for Mechanical Forces in the Detachment of Podocytes and the Progression of CKD
Wilhelm Kriz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
Hyun Mi Kang et al.
NATURE MEDICINE (2015)
Interleukin-22 in kidney injury and regeneration
Marc Weidenbusch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Thrombomodulin domain 1 ameliorates diabetic nephropathy in mice via anti-NF-κB/NLRP3 inflammasome-mediated inflammation, enhancement of NRF2 antioxidant activity and inhibition of apoptosis
Shun-Min Yang et al.
DIABETOLOGIA (2014)
Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes
Xiaoting Wang et al.
NATURE (2014)
Therapeutic opportunities of the IL-22-IL-22R1 system
Robert Sabat et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Tubulointerstitial disease in diabetic nephropathy
Giancarlo Tonolo et al.
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2014)
Renoprotective effects of olmesartan medoxomil on diabetic nephropathy in streptozotocin-induced diabetes in rats
Xiaofei Si et al.
BIOMEDICAL REPORTS (2014)
Inflammation and the pathogenesis of diabetic nephropathy
Jun Wada et al.
CLINICAL SCIENCE (2013)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Vlado Perkovic et al.
KIDNEY INTERNATIONAL (2013)
Angiopoietin-Like 3 Induces Podocyte F-Actin Rearrangement through Integrin αVβ3/FAK/PI3K Pathway-Mediated Rac1 Activation
Yi Lin et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The immune system and kidney disease: basic concepts and clinical implications
Christian Kurts et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
Ian H. de Boer et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Oxidative stress in early diabetic nephropathy: fueling the fire
Dhruv K. Singh et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Angiopoietin-like protein 3 regulates the motility and permeability of podocytes by altering nephrin expression in vitro
Xia Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Expression of Angiopoietin-Like 3 Associated with Puromycin-Induced Podocyte Damage
Rao Jia et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2010)
How does proteinuria cause progressive renal damage?
Mauro Abbate et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Podocyte. depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene
BL Wharram et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
The next generation of diabetic nephropathy therapies: An update
ME Williams et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2005)
Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: Paying homage to the podocyte
MR Hayden et al.
AMERICAN JOURNAL OF NEPHROLOGY (2005)
Why is proteinuria an ominous biomarker of progressive kidney disease?
K Zandi-Nejad et al.
KIDNEY INTERNATIONAL (2004)
Reactive oxygen species and matrix remodeling in diabetic kidney
H Ha et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Share Paper
